| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8816685 | American Journal of Preventive Medicine | 2017 | 5 Pages |
Abstract
Despite decreases, the absolute change in prostate-specific antigen testing for men aged 55-69 years was small (9.3%) over the study period. Men aged â¥70 years, for whom the benefits are unlikely to exceed the harms, continue to have consistently high testing prevalence.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Zahava MSPH, MSc, Jun MD, PhD, Thomas B. MD, Pamela M. PhD,